Dopamine

DB00988ApprovedInvestigationalSmall moleculeCatecholaminesSelective Beta 1-adrenergic Agonists

Dopamine is a catecholamine neurotransmitter used to treat hemodynamic imbalances, poor perfusion of vital organs, low cardiac output, and hypotension. One of the catecholamine neurotransmitters in the brain.

Chemical structure of Dopamine
Mechanism
Curator reviewed
Primary indication
For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failureCurator reviewed · 5 structured indications
Formula / weight
C8H11NO2 · 153.1784 g/mol (avg)
First approval
Canada, 2001 · United States, 1981 · European Union, 2024
Also known as
3-Hydroxytyramine · Oxytyramine
Code names
NSC-173182
Brand names
  • Neoatricon

Resolves to

Structure
InChIKeyVYFYYTLLBUKUHU-UHFFFAOYSA-NSMILESNCCC1=CC(O)=C(O)C=C1

What you can answer from here — as of September 23, 2026

17Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,316Drug interactionsStructured to mechanism, not free text
Sign in
90Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
134Marketed productsAcross 11 countries and 66 labellers
Sign in
1ATC codeIncluding every combination product, plus 29 drug categories
Sign in
95+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dopamine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account